Griffith University

Elke Kaemmerer

Name: Elke Kaemmerer
Position: Research Fellow
Research Area: Cancer
Qualifications: Diploma in Biology (equivalent to M.Sc.), Doctor of Natural Sciences (equivalent to PhD)

Elke graduated in 2010 from the Technische Universität (TU) Darmstadt, Germany, with a Diploma in Biology (equivalent to M.Sc.) and in 2014 was awarded a Doctor of Natural Sciences (equivalent to PhD degree) from TU Darmstadt, Department of Biology. Her PhD project investigated a bioengineered 3D cell culture system for ovarian cancer research and high resolution microscopy. She conducted research for her PhD project in Germany and Australia at the Department of Biology at TU Darmstadt and the Institute of Health and Biomedical Innovation at QUT, Australia. Upon completion of her PhD degree, Elke was a Research Fellow at the School of Pharmacy at UQ, with a research focus on calcium channels and pumps as novel targets to overcome therapeutic resistance in breast cancer. Elke joined the Discovery Biology team in July 2016 as part of the CTx initiative.

Discovery Biology:


Kaemmerer E, Rodriguez Garzon TE, Lock AM, Lovitt CJ Avery VM (2017) ‘Innovative in vitro models for breast cancer drug discovery’. Drug Discovery Today: Disease Models.  Invited review article. March 18; 21: 11-16.

Travel Awards:

2018Tony B. Academic Travel Award to attend the Society of Laboratory Automation and Screening International Conference and Exhibition; San Diego, USA

2016: Cancer Therapeutics CRC Award to attend the Oncology Drug Development in Practice course; Amsterdam, Netherlands

Committees and Memberships:

Serve on the Women in Technology (WiT) Life Sciences Committee

Member of the Society for Laboratory Automation and Screening (SLAS)



Kaemmerer  E, Turner D, Peters AA, Roberts-Thomson SJ, Monteith, GR (2018). ‘An automated epifluorescence microscopy imaging assay for the identification of phospho-AKT level modulators in breast cancer cells ’ Journal of pharmacological and toxicological methods 92 (2018): 13-19.

Azimi I, Milevskiy MJG, Kaemmerer E, Turner D, Yapa KTDS, Brown MA, Thompson EW, Roberts-Thomson SJ, Monteith GR (2017), ‘TRPC1 is a differential regulator of hypoxia-mediated events and Akt signaling in PTEN-deficient breast cancer cells’. J Cell Sci (2017): jcs-196659. 2017 May 23.

Pera E1, Kaemmerer E1, Milevskiy MJG, Yapa KTDS, O’Donnell JS, Brown MA, Simpson F, Peters AA, Roberts-Thomson SJ, Monteith GR (2016). ‘The voltage gated Ca(2+)-channel Cav3.2 and therapeutic responses in breast cancer’. Cancer Cell Int. 2016 Mar 31,16:24.

Loessner D, Meinert C, Kaemmerer E, Martine LC, Yue K, Levett PA, Klein TJ, Melchels FPW, Khademhosseini A, Hutmacher DW (2016). ‘Functionalization, preparation and use of cell-laden gelatin methacryloyl–based hydrogels as modular tissue culture platforms.’ Nature Protoc. 2016 Apr 11(4) 727-46. Epub 2016 Mar 17.

Holzapfel NP, Holzapfel BM, Theodoropoulos C, Kaemmerer E, Rausch T, Feldthusen J, Champ S, Clements JA, Hutmacher DW, Loessner D (2016).  ‘Lycopene’s effects on cancer cell functions within monolayer and spheroid cultures’. Nutr Cancer 2016, 68(2):350-63. Epub 2016 Mar 25.

Lauer FM1, Kaemmerer E1, Meckel T. (2014) ‘Single molecule microscopy in 3D cell cultures and tissues’. Adv Drug Deliv Rev. 2014 Dec 15;79-80:79-94. Epub 2014 Oct 18. Invited review article.

Kaemmerer E, Melchels FPW, Holzapfel BM, Meckel T, Hutmacher DW, Loessner D. (2014).‘Gelatine methacrylamide-based hydrogels: an alternative three-dimensional cancer cell culture system’. Acta Biomater. 2014 Jun;10(6):2551-62. Epub 2014 Feb 28.